PDX Pharmaceuticals Secures Additional Investment from the Kuni Foundation to Advance New Cancer-Fighting Precision Therapies
By Kuni Foundation | | Cancer ResearchPortland, Oregon -- PDX Pharmaceuticals, a privately held company developing first-in-class nanotechnology-based therapies for treating cancer, received a seco…
Kuni Foundation Appoints John G. Hunter, MD to Board of Directors
By Kuni Foundation |Vancouver, Washington – The Kuni Foundation is pleased to announce the appointment of John G. Hunter, MD to the organization’s Board of Directors. Dr. Hunter s…
Kuni Foundation Makes Direct Investment in Company to Advance New Cancer-Fighting Precision Therapy
By Kuni Foundation | | Cancer ResearchVancouver, Washington -- PDX Pharmaceuticals, a privately held company pioneering a new class of therapeutics based on co-delivery of siRNA and drugs on immuno…
News and Resources
Collaboration, curiosity and continuous learning are integral to our work. By sharing resources, insights and the stories that connect and inspire us, we hope you leave this site with a little more knowledge and perspective—and the desire to learn more.And, learning is a two-way street. If you have a resource you’d like to share, we’d love to see it! Submit a Resource